Teva Pharmaceutical Industries Ltd.’s Erez Vigodman will step down as chief executive officer, three years after being hired to turn around the Israeli drugmaker. Chairman Yitzhak Peterburg will serve as interim CEO while the company looks for a replacement, Teva said in a statement Monday.